Nolan Sean P. (CIK 1569926) reported 9 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-05-15). Recent activity: Buy VTR (2,047 shares), Buy VTR (36 shares), Buy VTR (27 shares), Buy VTR (50 shares), Buy VTR (37 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-15 | Ventas, Inc. (VTR) | Director | Buy | 2,047 | $184,946 |
| 2026-02-17 | Ventas, Inc. (VTR) | Director | Buy | 36 | $997 |
| 2026-02-17 | Ventas, Inc. (VTR) | Director | Buy | 27 | $924 |
| 2026-02-17 | Ventas, Inc. (VTR) | Director | Buy | 50 | $1,385 |
| 2026-02-17 | Ventas, Inc. (VTR) | Director | Buy | 37 | $1,266 |
| 2026-01-27 | Taysha Gene Therapies, Inc. (TSHA) | Chief Executive Officer | Sell | 136,789 | $649,748 |
| 2026-01-27 | Taysha Gene Therapies, Inc. (TSHA) | Chief Executive Officer | Sell | 41,312 | $190,448 |
| 2026-01-14 | Taysha Gene Therapies, Inc. (TSHA) | Chief Executive Officer | Buy | 1.0M | $0 |
| 2025-05-15 | Ventas, Inc. (VTR) | Director | Buy | 2,882 | $184,967 |
Source: SEC Form 4 filings · as of 2026-05-15